A method comprising: providing a treatment fluid comprising an aqueous base fluid and a controlled wetting system that comprises: a water soluble polymer comprising acrylamide and an ionic comonomer, present in an amount of 0.01% to 3% by weight of the treatment fluid; a cationic surfactant selected from the group consisting of an alkyl quaternaryammonium compound, an alkyl trialkylammonium bromide, a dialkyldiethylammonium chloride, a polyethoxylated alkylammmonium chloride, a alkyldimethylbenzylammonium chloride, an alkylpyridinium chloride, an alkyl diammonium pentamethyl chloride, and any combination thereof, present in an amount of 0.001% to 3% by volume of the treatment fluid; and a compatibilizer selected from the group consisting of an alkyl ethoxylate, an alkyl phenol ethoxylate, a sorbitan fatty acid ester, an ethoxylated sorbitan fatty acid ester, an alkyl polyglocoside, an ethoxylated alkylamine, a polyamine-ethoxylated diamine, an alkylpropoxylated amine, a fatty alcohol, an alkylamide monoethanolamine, an alkylamide diethanolamine, an alkyldialkylamine oxide, an alkylamide, an ethoxylated amides alkoxylated alkyl phenol, an alkoxylated alcohol, a polyol, a polyol ester, an alkylamidopropyl betaine, an alkyliminodipropionate disodium, an alkylamphodiacetate disodium, an alkylampho hydroxypropyl sulfonate sodium, an alkylamidopropylhydroxysultaine, a lecithin, and any combination thereof, present in an amount of 0.001% to 3% by volume of the treatment fluid; and introducing the treatment fluid into a subterranean formation. providing a treatment fluid comprising an aqueous base fluid and a controlled wetting system that comprises: a water soluble polymer comprising acrylamide and an ionic comonomer, present in an amount of 0.01% to 3% by weight of the treatment fluid; a cationic surfactant selected from the group consisting of an alkyl quaternaryammonium compound, an alkyl trialkylammonium bromide, a dialkyldiethylammonium chloride, a polyethoxylated alkylammmonium chloride, a alkyldimethylbenzylammonium chloride, an alkylpyridinium chloride, an alkyl diammonium pentamethyl chloride, and any combination thereof, present in an amount of 0.001% to 3% by volume of the treatment fluid; and a compatibilizer selected from the group consisting of an alkyl ethoxylate, an alkyl phenol ethoxylate, a sorbitan fatty acid ester, an ethoxylated sorbitan fatty acid ester, an alkyl polyglocoside, an ethoxylated alkylamine, a polyamine-ethoxylated diamine, an alkylpropoxylated amine, a fatty alcohol, an alkylamide monoethanolamine, an alkylamide diethanolamine, an alkyldialkylamine oxide, an alkylamide, an ethoxylated amides alkoxylated alkyl phenol, an alkoxylated alcohol, a polyol, a polyol ester, an alkylamidopropyl betaine, an alkyliminodipropionate disodium, an alkylamphodiacetate disodium, an alkylampho hydroxypropyl sulfonate sodium, an alkylamidopropylhydroxysultaine, a lecithin, and any combination thereof, present in an amount of 0.001% to 3% by volume of the treatment fluid; and introducing the treatment fluid into a subterranean formation. a water soluble polymer comprising acrylamide and an ionic comonomer, present in an amount of 0.01% to 3% by weight of the treatment fluid; a cationic surfactant selected from the group consisting of an alkyl quaternaryammonium compound, an alkyl trialkylammonium bromide, a dialkyldiethylammonium chloride, a polyethoxylated alkylammmonium chloride, a alkyldimethylbenzylammonium chloride, an alkylpyridinium chloride, an alkyl diammonium pentamethyl chloride, and any combination thereof, present in an amount of 0.001% to 3% by volume of the treatment fluid; and a compatibilizer selected from the group consisting of an alkyl ethoxylate, an alkyl phenol ethoxylate, a sorbitan fatty acid ester, an ethoxylated sorbitan fatty acid ester, an alkyl polyglocoside, an ethoxylated alkylamine, a polyamine-ethoxylated diamine, an alkylpropoxylated amine, a fatty alcohol, an alkylamide monoethanolamine, an alkylamide diethanolamine, an alkyldialkylamine oxide, an alkylamide, an ethoxylated amides alkoxylated alkyl phenol, an alkoxylated alcohol, a polyol, a polyol ester, an alkylamidopropyl betaine, an alkyliminodipropionate disodium, an alkylamphodiacetate disodium, an alkylampho hydroxypropyl sulfonate sodium, an alkylamidopropylhydroxysultaine, a lecithin, and any combination thereof, present in an amount of 0.001% to 3% by volume of the treatment fluid; and introducing the treatment fluid into a subterranean formation.